taar13c Antibody

What is TAAR13c and why is it significant for olfactory research?

TAAR13c is a G Protein-Coupled Receptor (GPCR) belonging to the trace amine-associated receptor family found in zebrafish. It has particular significance in olfactory research as it functions as a high-affinity detector for cadaverine (1,5-diaminopentane) and related aliphatic diamines . These diamines are death-associated odors that emanate from decaying flesh, which trigger innate avoidance behaviors in zebrafish . The receptor exhibits a non-classical mode of amine recognition, utilizing an alternative structural mechanism for ligand binding compared to other amine receptors . TAAR13c is predominantly expressed in a sparse population of olfactory sensory neurons (approximately 0.3 cells per lamella) with ciliary morphology, consistent with the expected frequency for individual olfactory receptor gene expression .

How specific is the TAAR13c antibody and what epitopes does it recognize?

The TAAR13c antibody is highly specific, designed to recognize a highly divergent region of the TAAR13c sequence that is not conserved in closely related TAAR13 family members . This specificity is critical since the zebrafish genome contains multiple TAAR13 family members with substantial sequence similarity. In western blot analysis, the antibody selectively labels a 55-kDa protein in olfactory epithelium but not in other tissues, confirming its specificity . When used for immunohistochemistry (IHC), the antibody labels an extremely sparse neuronal population consistent with the expected expression pattern of individual olfactory receptor genes . The careful design targeting a divergent region ensures minimal cross-reactivity with other TAAR13 family proteins, though some studies show that riboprobes may cross-hybridize with other family members at a higher rate than the antibody .

What are the basic applications of TAAR13c antibodies in neurosensory research?

TAAR13c antibodies serve several fundamental applications in neurosensory research:

• Cellular localization: The antibody enables precise identification of TAAR13c-expressing neurons within the olfactory epithelium through immunohistochemistry .

• Protein expression verification: Western blot analysis using the antibody confirms the presence and molecular weight (55-kDa) of the TAAR13c protein in olfactory tissues .

• Functional correlation studies: The antibody facilitates two-color IHC analysis with activity markers such as phosphorylated ERK (pERK) to correlate receptor expression with neuronal responses to specific odorants .

• Receptor specificity studies: When combined with ligand exposure experiments, the antibody helps demonstrate the ligand specificity profile of TAAR13c-expressing neurons, showing their preference for odd-chained diamines like cadaverine over even-chained ones like putrescine .

• Validation of receptor models: The antibody helps validate computational models of TAAR13c structure by confirming the expression of wild-type and mutant receptors in experimental systems .

How can researchers effectively design experiments to study ligand-specific activation of TAAR13c-expressing neurons?

To effectively design experiments investigating ligand-specific activation of TAAR13c-expressing neurons, researchers should consider the following methodological approach:

• Two-color IHC analysis: Utilize the TAAR13c antibody in combination with activity-dependent markers like phosphorylated ERK (pERK). This approach allows you to simultaneously visualize receptor expression and neuronal activation .

• Dose-response experimental design: Test a range of ligand concentrations (e.g., from 1-3 μM threshold to >100 μM) to distinguish between high-affinity and low-affinity responses. Research shows high-affinity cadaverine responses (at 10 μM) occur primarily (~90%) in TAAR13c-expressing cells, while higher concentrations recruit additional neuronal populations .

• Ligand specificity panels: Include structurally related diamines of varying carbon chain lengths (C3-C10) in your experiments, as TAAR13c shows differential affinity based on carbon chain length, with preference for odd-chained diamines (C5, C7) .

• Cross-adaptation protocols: Implement cross-adaptation studies similar to those showing limited cross-adaptation between cadaverine and putrescine responses, to identify potential receptor overlap or independence .

• Physiologically relevant stimuli: Include natural stimuli such as tissue extracts at various stages of decomposition to validate receptor function in biologically meaningful contexts. Studies show TAAR13c can detect cadaverine in complex mixtures from decomposing fish tissue .

• Genetic validation: Consider using morpholino knockdown or CRISPR-based approaches targeting TAAR13c to confirm the causal relationship between receptor expression and observed neuronal responses.

What are the key considerations when interpreting seemingly contradictory data between in vitro receptor activity and in vivo neuronal responses?

When confronted with apparent contradictions between in vitro TAAR13c receptor activity and in vivo neuronal responses, researchers should systematically consider several factors:

To reconcile such contradictions, researchers should consider combining approaches such as:

• Two-color analysis with TAAR13c antibody and activity markers

• Genetic manipulation of receptor expression

• Cross-adaptation studies

• Use of structurally related ligands to construct comprehensive structure-activity relationships

How can TAAR13c antibodies be effectively combined with other molecular tools to study signal transduction mechanisms?

Researchers can combine TAAR13c antibodies with multiple molecular tools to comprehensively investigate signal transduction mechanisms:

• Reporter gene systems: Pair antibody labeling with reporter gene assays (such as the cAMP-dependent Cre-SEAP system) to correlate receptor expression with functional activity. This approach has been successfully used to characterize TAAR13c responses to various ligands and to assess the impact of point mutations .

• Site-directed mutagenesis: Combine the antibody with mutational analysis of key residues such as:

  • Asp112^3.32 (canonical amine-binding site)

  • Asp202^5.42 (non-canonical amine-binding site)

  This approach revealed that mutation of Asp202^5.42 transforms TAAR13c from a diamine receptor into a monoamine receptor, demonstrating its role in ligand specificity .

• Molecular modeling and structural analysis: Use antibody validation of expression alongside homology modeling based on related GPCRs (such as the β2 adrenergic receptor). This combined approach has revealed:

  • The dual aspartate recognition mechanism for diamines

  • The structural basis for odd-chained diamine preference

  • The role of transmembrane domains in ligand binding

• Optogenetic or chemogenetic tools: Co-express opsins or DREADDs in TAAR13c-positive neurons (identified by antibody labeling) to manipulate their activity and establish causal relationships between receptor activation and behavioral responses.

• Calcium imaging: Combine antibody labeling with calcium indicators to monitor real-time activity of TAAR13c-expressing neurons in response to ligands, providing temporal information about signaling dynamics.

• Phospho-specific antibodies: Use phospho-specific antibodies against components of the cAMP signaling pathway alongside TAAR13c antibodies to track signal transduction events following receptor activation.

What are the most robust controls and validation steps when using TAAR13c antibodies for immunohistochemistry?

When employing TAAR13c antibodies for immunohistochemistry, the following controls and validation steps are essential for ensuring experimental rigor:

• Specificity controls:

  • Peptide competition/blocking: Pre-absorb the antibody with the immunizing peptide to confirm signal elimination.

  • Tissue specificity: Compare labeling between olfactory epithelium (positive) and non-expressing tissues (negative). Research confirms TAAR13c antibody labels proteins in olfactory epithelium but not in other tissues .

  • Western blot validation: Confirm that the antibody recognizes a protein of the expected molecular weight (55-kDa for TAAR13c) in target tissues .

• Technical controls:

  • Secondary antibody-only controls: Omit primary antibody to assess non-specific binding.

  • Isotype controls: Use an irrelevant antibody of the same isotype to evaluate background.

  • Cross-species reactivity testing: Verify whether the antibody cross-reacts with homologous proteins in related species if performing comparative studies.

• Methodological validation:

  • Dual labeling with in situ hybridization: Confirm co-localization of protein and mRNA expression. Studies show co-labeling of TAAR13c antibody with Taar13c cRNA riboprobe .

  • Genetic models: If available, test antibody on knockout or overexpression models to confirm specificity.

  • Multiple fixation protocols: Test performance under different fixation conditions to optimize signal-to-noise ratio.

• Functional validation:

  • Correlation with functional responses: Use two-color IHC to correlate antibody labeling with activation markers (e.g., pERK) following ligand exposure .

  • Quantitative assessment: Determine the frequency of labeled cells and compare with expected expression patterns for individual olfactory receptors (approximately 0.3 cells per lamella for TAAR13c) .

What is the optimal protocol for using TAAR13c antibodies in western blot analysis?

Optimal Western Blot Protocol for TAAR13c Antibody

Sample Preparation:

• Dissect olfactory epithelium from freshly sacrificed zebrafish.

• Homogenize tissue in RIPA buffer containing protease inhibitor cocktail.

• Centrifuge homogenate at 14,000 × g for 15 minutes at 4°C.

• Determine protein concentration using Bradford or BCA assay.

• Prepare samples (20-30 μg protein) in Laemmli buffer with β-mercaptoethanol.

• Heat samples at 95°C for 5 minutes.

Gel Electrophoresis and Transfer:

• Separate proteins on a 10% SDS-PAGE gel (optimal for the 55-kDa TAAR13c protein) .

• Transfer proteins to PVDF membrane at 100V for 60-90 minutes in cold transfer buffer.

Immunoblotting:

• Block membrane in 5% non-fat dry milk in TBST for 1 hour at room temperature.

• Incubate with primary TAAR13c antibody (1:1000 dilution) overnight at 4°C.

• Wash 3× with TBST, 10 minutes each.

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature.

• Wash 3× with TBST, 10 minutes each.

• Develop using enhanced chemiluminescence substrate.

Critical Controls:

• Positive control: Olfactory epithelium tissue lysate (should show a band at 55-kDa) .

• Negative control: Non-olfactory tissue lysates (should not show specific bands) .

• Peptide competition control: Pre-incubate antibody with immunizing peptide.

• Loading control: Probe for housekeeping protein (β-actin or GAPDH).

Troubleshooting Tips:

• If signal is weak, try longer exposure times or increased antibody concentration.

• If background is high, increase washing duration or adjust blocking conditions.

• If multiple bands appear, optimize sample preparation or consider testing tissue from TAAR13c knockout models.

What is the recommended immunohistochemistry protocol for visualizing TAAR13c-expressing neurons?

Recommended Immunohistochemistry Protocol for TAAR13c-Expressing Neurons

Tissue Preparation:

• Fix zebrafish heads in 4% paraformaldehyde in PBS for 2 hours at room temperature.

• Decalcify in 0.5M EDTA (pH 8.0) for 24-48 hours at 4°C.

• Cryoprotect in 30% sucrose in PBS overnight at 4°C.

• Embed in OCT compound and freeze on dry ice.

• Section at 10-14 μm thickness using a cryostat and mount on positively charged slides.

Immunostaining:

• Air-dry sections for 30 minutes at room temperature.

• Wash 3× in PBS, 5 minutes each.

• Perform antigen retrieval if necessary (heat-mediated in citrate buffer, pH 6.0).

• Block in 5% normal serum with 0.3% Triton X-100 in PBS for 1 hour.

• Incubate with TAAR13c antibody (1:500 dilution) in blocking solution overnight at 4°C.

• Wash 3× in PBS, 10 minutes each.

• Incubate with fluorophore-conjugated secondary antibody (1:1000) for 2 hours at room temperature.

• Wash 3× in PBS, 10 minutes each.

• Counterstain with DAPI (1:1000) for 5 minutes.

• Wash briefly in PBS.

• Mount with anti-fade mounting medium.

For Dual Labeling with Activity Markers:

• After TAAR13c antibody labeling, incubate with anti-pERK antibody (1:500) overnight at 4°C.

• Wash 3× in PBS, 10 minutes each.

• Incubate with spectrally distinct secondary antibody (1:1000) for 2 hours.

• Continue with washing and counterstaining as above.

Expected Results:

• TAAR13c immunoreactivity should be visible in approximately 0.3 cells per lamella in the olfactory epithelium .

• Labeled neurons should display ciliary morphology .

• When combined with functional assays, approximately 90% of neurons responding to 10 μM cadaverine should be TAAR13c-positive .

How should researchers design functional experiments to correlate TAAR13c expression with odor responses?

Experimental Design for Correlating TAAR13c Expression with Odor Responses

1. Two-Color IHC Protocol for pERK and TAAR13c:

This approach allows for simultaneous visualization of receptor expression and neuronal activation:

Sample Preparation:

• Expose live zebrafish to test odorants (diamines at various concentrations) or control solutions for 5-7 minutes.

• Immediately euthanize and fix in 4% paraformaldehyde.

• Process tissue as described in the IHC protocol.

Staining Procedure:

• Follow the standard IHC protocol for TAAR13c antibody.

• For pERK co-labeling, include anti-pERK antibody (1:500) during primary antibody incubation.

• Use spectrally distinct secondary antibodies to differentiate the signals.

Analysis:

• Quantify the percentage of TAAR13c-positive neurons that are also pERK-positive after stimulation.

• Compare responses across different odorants and concentrations.

• Expected result: ~90% of neurons responding to 10 μM cadaverine should be TAAR13c-positive .

2. Dose-Response Analysis Design:

3. Alternative Functional Approaches:

Calcium Imaging with TAAR13c Identification:

• Use genetically encoded calcium indicators in zebrafish olfactory neurons.

• Record responses to diamine application.

• Fix tissue immediately after imaging.

• Perform post-hoc IHC for TAAR13c to identify recorded neurons.

• Correlate calcium responses with TAAR13c expression.

Electrophysiological Recording:

• Perform patch-clamp recordings from olfactory sensory neurons.

• Test responses to diamines of various chain lengths.

• Fill recorded cells with biocytin for post-hoc identification.

• Process tissue for TAAR13c IHC to correlate electrophysiological responses with receptor expression.

4. Cross-Adaptation Experimental Design:

To verify receptor specificity and potential overlap:

• Apply first odorant (e.g., cadaverine) continuously.

• During adaptation, pulse with second odorant (e.g., putrescine).

• Fix tissue and perform two-color IHC for TAAR13c and pERK.

• Analyze which populations adapt and which show cross-adaptation.

What approaches can researchers use to validate the specificity of TAAR13c antibodies?

Comprehensive Antibody Validation Strategy for TAAR13c

1. Molecular Validation:

Western Blot Analysis:

• Protein size verification: Confirm single band at expected molecular weight (55-kDa) in olfactory epithelium .

• Tissue specificity: Test various tissues (brain, heart, liver, etc.) to confirm absence of signal in non-olfactory tissues .

• Peptide competition: Pre-incubate antibody with immunizing peptide to eliminate specific signal.

Immunoprecipitation:

• Perform IP with TAAR13c antibody from olfactory epithelium lysate.

• Analyze pulled-down protein by mass spectrometry to confirm identity.

• Verify absence of closely related TAAR family members in the immunoprecipitate.

2. Genetic Validation:

Comparison with RNA Expression:

• Co-labeling with Taar13c RNA riboprobes to confirm overlapping expression patterns .

• Quantify correlation between protein and mRNA detection.

• Note: RNA probes may show 3-6 fold more cells due to cross-hybridization with related family members .

Knockout/Knockdown Approaches:

• Generate CRISPR/Cas9 knockout zebrafish for TAAR13c.

• Test antibody on knockout tissue to confirm signal elimination.

• Alternatively, use morpholino knockdown with appropriate controls.

Heterologous Expression:

• Express TAAR13c in cell lines (e.g., HEK293).

• Perform IHC on transfected vs. non-transfected cells.

• Include related receptors (other TAAR13 family members) to test cross-reactivity.

3. Functional Validation:

Structure-Function Analysis:

• Generate point mutations in key residues (e.g., D112A, D202A) .

• Confirm antibody detection of mutant proteins.

• Correlate protein detection with functional studies using reporter assays .

Ligand-Induced Activity:

• Expose fish to cadaverine or control solutions.

• Perform two-color IHC for TAAR13c and activity markers (pERK).

• Quantify the percentage of TAAR13c+ cells showing activation .

• Compare percentage to functional data: ~90% of high-affinity cadaverine-responsive cells should be TAAR13c+ .

4. Technical Validation:

Reproducibility Testing:

• Test antibody across multiple lots.

• Validate in multiple laboratories.

• Use different detection systems (fluorescent vs. chromogenic).

Dilution Series:

• Test antibody at multiple dilutions (1:100 to 1:10,000).

• Determine optimal signal-to-noise ratio.

• Document specificity across concentration range.

Fixation Optimization:

• Compare antibody performance across fixation methods (PFA, methanol, acetone).

• Determine optimal fixation time and conditions.

• Test requirement for antigen retrieval methods.

What are the current limitations of TAAR13c antibodies and how might they be addressed?

Current Limitations and Future Solutions for TAAR13c Antibodies

1. Cross-Reactivity Concerns:

Current Limitation: While the TAAR13c antibody targets a divergent region to minimize cross-reactivity , the high sequence similarity between TAAR13 family members (TAAR13a-e) creates potential for some cross-recognition.

Potential Solutions:

• Develop monoclonal antibodies targeting unique epitopes with even higher specificity.

• Implement epitope mapping to identify the precise binding region.

• Validate antibodies against all TAAR13 family members expressed in heterologous systems.

• Develop knockout models for definitive validation.

2. Sensitivity Limitations:

Current Limitation: Low expression levels of TAAR13c (approximately 0.3 cells per lamella) challenge detection limits of conventional IHC.

Potential Solutions:

• Employ signal amplification methods such as tyramide signal amplification (TSA).

• Develop higher-affinity antibodies through affinity maturation.

• Use multiplex approaches combining antibody detection with genetic approaches (e.g., fluorescent reporter knock-ins).

• Implement super-resolution microscopy techniques to enhance detection of sparse signals.

3. Species Cross-Reactivity:

Current Limitation: Current antibodies are optimized for zebrafish studies, limiting comparative analyses across species.

Potential Solutions:

• Develop antibodies against conserved epitopes for cross-species applications.

• Create species-specific antibodies for comparative studies.

• Establish validation protocols for each species of interest.

• Employ synthetic antibody technologies to target conserved functional domains.

4. Quantitative Analysis Challenges:

Current Limitation: Current applications focus on qualitative detection rather than precise quantification of receptor levels.

Potential Solutions:

• Develop calibrated quantitative immunoassays specific for TAAR13c.

• Implement standardized image analysis pipelines for consistent quantification.

• Use internal reference standards for normalization across experiments.

• Combine with absolute quantification methods (e.g., mass spectrometry) for calibration.

How can TAAR13c antibody research contribute to understanding evolutionary conservation of olfactory mechanisms?

TAAR13c antibody-based research offers several avenues for exploring evolutionary conservation of olfactory mechanisms:

• Comparative receptor expression mapping: By adapting TAAR13c antibodies or developing homologous antibodies for related species, researchers can map the expression patterns of diamine receptors across vertebrates. This would reveal whether:

  • The sparse expression pattern (0.3 cells per lamella) is evolutionarily conserved

  • The cellular morphology (ciliary) of expressing neurons is consistent across species

  • Receptor distribution patterns correlate with ecological niches and behavioral responses

• Structural evolution analysis: TAAR13c represents a fascinating case of non-classical amine recognition, utilizing Asp^5.42 instead of the canonical Asp^3.32 for binding one amine group . Antibody-based studies combined with functional assays can reveal:

  • When this alternative binding mechanism evolved

  • Whether it represents convergent or divergent evolution

  • How widespread this mechanism is across species

  • Correlation between structural adaptations and ecological niches

• Ligand preference evolution: TAAR13c shows preference for odd-chained diamines like cadaverine . Cross-species studies using TAAR13c antibodies in combination with functional assays could elucidate:

  • How ligand preferences evolved in relation to ecological factors

  • Whether odd-chain diamine preference is conserved across species

  • If receptor sensitivity correlates with ecological relevance of diamines

• Signaling pathway conservation: Using TAAR13c antibodies alongside markers of downstream signaling components can reveal:

  • Conservation of signal transduction mechanisms across species

  • Evolution of specialized signaling complexes

  • Adaptation of signaling kinetics to ecological demands

• Behavioral correlation studies: Combining TAAR13c antibody labeling with behavioral assays across species can establish:

  • Correlation between receptor expression patterns and behavioral sensitivity

  • Conservation of innate avoidance behaviors to diamines across vertebrates

  • Relationship between receptor adaptations and behavioral specializations

What technical advances might improve the usefulness of TAAR13c antibodies for multi-omics approaches?

Several technical advances could significantly enhance the utility of TAAR13c antibodies in multi-omics research approaches:

• Single-cell proteogenomics integration:

  • Development of TAAR13c antibodies compatible with Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq)

  • This would allow simultaneous detection of TAAR13c protein expression and whole-transcriptome analysis at single-cell resolution

  • Could reveal previously unknown molecular signatures of TAAR13c-expressing neurons

  • Would enable identification of co-expressed receptors and signaling components

• Proximity labeling applications:

  • Engineering TAAR13c antibody-enzyme fusions (e.g., with APEX2, BioID, or TurboID)

  • These would enable spatial proteomics around TAAR13c-expressing neurons

  • Could identify protein interaction networks specific to these specialized sensory neurons

  • Would reveal molecular components of the signal transduction pathway in native contexts

• Antibody-guided laser capture microdissection:

  • Optimization of TAAR13c antibodies for compatibility with laser capture methods

  • This would enable selective isolation of TAAR13c-expressing neurons for multi-omics analysis

  • Could be combined with spatial transcriptomics or proteomics approaches

  • Would provide comprehensive molecular profiles of these specialized neurons

• Mass cytometry (CyTOF) adaptation:

  • Development of metal-conjugated TAAR13c antibodies

  • This would enable high-dimensional analysis of olfactory neurons

  • Could be combined with antibodies against numerous signaling molecules and neuronal markers

  • Would provide unprecedented resolution of neuronal heterogeneity

• Expansion microscopy compatibility:

  • Optimization of TAAR13c antibodies for expanded specimens

  • This would enable super-resolution imaging of receptor distribution

  • Could reveal subcellular localization patterns not visible with conventional microscopy

  • Would facilitate detailed morphological characterization of TAAR13c-expressing neurons

How might TAAR13c antibodies contribute to understanding the neural circuitry of innate avoidance behaviors?

TAAR13c antibodies offer powerful tools for elucidating the neural circuitry underlying innate avoidance behaviors to diamines:

• Circuit tracing from identified neurons:

  • Combine TAAR13c antibody labeling with retrograde and anterograde neural tracers

  • This would reveal:

    • Second-order neurons receiving input from TAAR13c-expressing cells

    • Projection patterns to higher brain regions

    • Circuit nodes responsible for converting sensory detection into avoidance behavior

  • Expected outcome: Mapping of direct connections between TAAR13c-expressing neurons and specific glomeruli in the olfactory bulb, followed by connections to brain regions mediating aversive responses

• Activity mapping during behavioral responses:

  • Use TAAR13c antibodies in combination with immediate early gene markers (c-Fos, pERK) following:

    • Exposure to cadaverine

    • Exposure to natural decomposing tissue

    • During active avoidance behaviors

  • This approach would identify:

    • Active circuit components during avoidance

    • Potential modulatory influences on the circuit

    • Correlation between neuronal activity and behavioral intensity

• Functional manipulation strategies:

  • Identify TAAR13c-expressing neurons using antibodies, then:

    • Target these neurons for optogenetic or chemogenetic manipulation

    • Selectively ablate these neurons and assess behavioral consequences

    • Record from identified neurons during behavior

  • This would establish:

    • Causal relationship between TAAR13c activation and behavior

    • Necessity and sufficiency of these neurons for avoidance

    • Temporal dynamics of neural activity during behavioral execution

• Comparative circuit analysis:

  • Use TAAR13c antibodies across species with different behavioral responses to diamines

  • Compare:

    • Circuit architecture

    • Connectivity patterns

    • Co-expression of modulatory receptors

  • This would reveal:

    • Evolutionary conservation of avoidance circuits

    • Neural substrate differences underlying species-specific behaviors

    • Adaptations related to ecological niches

• Developmental circuit formation:

  • Apply TAAR13c antibodies across developmental stages to track:

    • When TAAR13c-expressing neurons first appear

    • How their connectivity develops

    • Whether exposure to diamines during development affects circuit formation

  • This would elucidate:

    • Critical periods for establishing avoidance behaviors

    • Developmental mechanisms ensuring appropriate circuit wiring

    • Potential plasticity in innate behavior circuits

By integrating these approaches, researchers can construct a comprehensive understanding of how the detection of death-associated odors by TAAR13c-expressing neurons is transformed into adaptive avoidance behaviors at the circuit level.